European Market Report for Insulin Syringes 2016 - MedCore
The insulin syringe market is a fast declining segment. Although the product was once a popular method of injecting insulin, patients have transitioned towards new technologies such as insulin pens and pumps, thereby cannibalizing the insulin syringe segment. Safety insulin syringes are now mainly used in professional healthcare settings, such as hospitals, whereas conventional syringes are no longer used as frequently. Syringe use is still relatively high in Italy due to historical trends, but it is expected that patients will continue to switch to insulin pens and pumps for convenience.
Insulin is a protein and when administered orally, it degrades in the stomach and the intestines. When administered subcutaneously, it is better absorbed and has more of an effect on blood sugar levels. Many alternative technologies have entered the insulin delivery device market, such as insulin pumps and insulin pens, resulting in a fast decline in insulin syringe use across Europe.
Insulin syringes are moving from being hypodermic to those with finer points. Syringes are used with 10 mL insulin vials and come in 0.3 mL, 0.5 mL and 1 mL calibrations. In addition, thinner and shorter syringes are becoming more popular in the market, as they cause less discomfort when giving an injection. Needle thickness is indicated by gauge number; the higher the gauge number, the thinner the needle.